Apr 25, 2024 04:01 PM
Smruthi Organics Ltd
SECTOR : Pharmaceuticals | BSE :540686 |
Financials( ₹ in Cr) | Smruthi Organics Ltd | Sun Pharmaceuticals Industries Ltd | Cipla Ltd | Dr Reddys Laboratories Ltd | Divis Laboratories Ltd |
---|---|---|---|---|---|
Price | 155.10 | 1,520.15 | 1,406.20 | 6,218.75 | 3,843.80 |
% Change | -2.08 | 2.32 | 0.57 | 4.50 | 0.79 |
Mcap ₹ Cr | 177.53 | 364,734.91 | 113,531.95 | 103,739.94 | 102,040.97 |
Revenue TTM ₹ Cr | 141.04 | 43,885.68 | 15,790.60 | 24,669.70 | 7,767.51 |
Net Profit TTM ₹ Cr | 4.13 | 8,560.84 | 2,513.47 | 4,507.30 | 1,823.38 |
PE TTM | 65.75 | 38.89 | 28.70 | 19.84 | 73.72 |
1 Year Return | 9.65 | 55.25 | 55.73 | 29.39 | 20.39 |
ROCE | 7.23 | 16.79 | 14.76 | 25.99 | 19.30 |
ROE | 6.10 | 16.46 | 10.66 | 21.21 | 14.89 |
Equity Capital: 68.16 Cr FV: 10.00
Period | MF Net Purchase / (sold) | FII Net |
---|---|---|
LAST 1M | 20,210.21 | -2,288.40 |
LAST 3M | 84,754.55 | 29,178.29 |
LAST 6M | 143,739.62 | 78,000.86 |
LAST 12M | 219,616.53 | 194,185.36 |
Date | Action Type | Ratio |
---|---|---|
Jul 28, 2023 | Dividend | 20 |
Jul 28, 2022 | Dividend | 30 |
Smruthi Organics Ltd was incorporated in July, 1989 as a private limited company and was subsequently converted into a public limited company in February, 1995. It was promoted by E Purushotham and Shankarrao R Myakal. The Company is a manufacturer of Active Pharmaceutical Ingredient (API) products in the Anti - Diabetic, Anti - Hypertension and Anti - Infectives Therapeutic categories catering to both the Indian domestic as well as rest of the world (ROW) markets, with clients spanning across Asia, Americas, and Africa. It has 2 manufacturing facilities in Solapur, India. The company set up a plant at Solapur, Maharashtra, to manufacture bulk drugs like diloxanide furoate (inst. cap. : 24 tpa) and sulphadiazine (inst. cap. : 36 tpa). It expanded its activities and product range in 1993-94 by manufacturing metronidazole benzoate, tinidazole, paracetamol and norfloxacin. The company exports furoic acid to the UK market. In 1995, it proposed to expand its product range and set up an additional plant at Chincholi, Maharashtra, for the manufacture of additional bulk drugs like ciprofloxacin and ranitidine HCl. The company issued shares to the public in Dec.`95, to part-finance the project. In 1993, the company received the district award as the Best Small Scale Entrepreneur in Solapur in the Year 1993, from the Government of Maharashtra. In 2011-12, the Company`s expansion project became commercialized from 21st September 2012. In 2021-22, the Company`s Finished Dosage Formulations (FDF) Division was operational fully from April 2021. In FY 2022-23, the Company launched two new brands, namely ENERLIN and SOLSITA.
165-A Balaji Bhavan 1st Floor, Railway Lines, Solapur, Maharashtra, 413001
Tel | : | 91-217-2310267/2310268 |
: | eaga:smruthiorganics.com | |
Website | : | http://www.smruthiorganics.com |
Adroit Corp. Services Pvt Ltd
AGM Date (Month) | : | Aug |
Face Value Equity Shares | : | 10 |
Market Lot Equity Shares | : | 1 |
BSE Code | : | 540686 |
NSE Code | : | |
Book Closure Date (Month) | : | Jul/Aug |
BSE Group | : | X |
ISIN | : | INE172E01011 |
You can buy Smruthi Organics Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Smruthi Organics Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Apr 25, 2024 04:01 PM the closing price of Smruthi Organics Ltd was ₹ 155.10.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 25, 2024 04:01 PM, the market cap of Smruthi Organics Ltd stood at ₹ 177.53.
The latest PE ratio of Smruthi Organics Ltd as of Apr 25, 2024 04:01 PM is 65.75
The latest PB ratio of Smruthi Organics Ltd as of Apr 25, 2024 04:01 PM is 0.40
The 52-week high of Smruthi Organics Ltd share price is ₹ 218.80 while the 52-week low is ₹ 117.00